ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 682242 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 682242; 2) Community: the network communities that were significantly associated with the response to NSC 682242; 3) Molecule: the relationships between components within communities and NSC 682242; 4) MDR: the compounds that were significantly associated with the NSC 682242.

NSC Compound Enrichment Correlation
NSC 649270 Benzo[d]naphtho[1,2-b]pyran-6-one, 1-hydroxy-10-methyl-7,8,9,10-tetrahydro- 0.00352002370824893 0.53380533
NSC 658450 2-Acetamido-6-methyl-8-hydroxy-1,4-naphthaquinone 0.00352002370824893 -0.3817897
NSC 666160 Bis[1-(4-methylpiperidino)-4-(2-pyridyl)-2,3-diazapenta 1,3-dien-1-thiolato-N',N3,S]nitrato-bismuth(III) 0.00352002370824893 -0.37828894
NSC 668324 Null 0.00352002370824893 -0.37464595
NSC 672141 Null 0.00352002370824893 -0.39760652
NSC 685860 Null 0.00352002370824893 0.64032869
NSC 706236 Null 0.00352002370824893 -0.27661073
NSC 758662 Lovastatin [USAN] 0.00352002370824893 0.42053944
NSC 620327 Carbonimidodithioic acid, [5-(4-nitrophenyl)-1,3,4- thiadiazol-2-yl]-, dimethyl ester 0.00407837248037202 0.67588317
NSC 637921 1H-Pyrazole-1-propanamide, 3,5-diphenyl- N-(4-methoxyphenyl)-4-[(4-methylphenyl)azo]-.beta.-oxo- 0.00407837248037202 0.72766085
Total:56  Current:7    [First] [Prev] [Next] [Last]